By Sola Ogundipe
With Helicobacter pylori infection affecting more than half of the world’s population and prevalence rates in parts of Africa exceeding 80 percent, medical experts are intensifying calls for stronger African-led research, improved diagnosis and more effective treatment strategies to tackle the growing public health challenge.
The bacterium, which colonises the stomach and can persist for years without obvious symptoms, is associated with chronic gastritis, peptic ulcer disease and gastric cancer. Yet, despite its widespread presence across the continent, gaps in surveillance, limited access to diagnostic facilities and growing antibiotic resistance continue to complicate efforts to control the infection
Africa records some of the world’s highest H. pylori prevalence rates, often exceeding 80 percent in some populations, compared with 25 to 50 per cent in high-income countries.
Although most infected people may not develop symptoms, the infection can lead to significant complications. An estimated 10 to 20 percent of infected individuals develop peptic ulcer disease, gastritis or duodenitis, while a smaller proportion develop gastric adenocarcinoma or other serious complications.
Of particular concern is antimicrobial resistance, which threatens the effectiveness of commonly prescribed treatment regimens. Findings raise concerns about the continued reliance on empirical antibiotic prescriptions without adequate knowledge of local resistance patterns, potentially contributing to treatment failure and repeated exposure to antibiotics.
Against this background, African and international experts are set to converge on Lusaka, Zambia, from November 27 to 28, 2026, for the 2nd African Helicobacter pylori and Microbiota Scientific Conference, organised by the African Helicobacter and Microbiota Study Group (AHMSG). The conference is expected to provide a platform for examining the changing landscape of H. pylori infection, its implications for gastrointestinal health in Africa and the urgent need for research and treatment approaches that reflect the continent’s peculiar health challenges.
At the forthcoming conference, Emeritus Professor Colm O’Morain of Trinity College Dublin and Tallaght University Hospital, Ireland, will deliver the keynote address on “The Next 40 Years of H. pylori: Opportunities and Challenges.”
His presentation is expected to examine emerging scientific developments, unresolved questions and opportunities for improving the prevention, diagnosis and treatment of the infection.
Another prominent speaker, Professor Yoshio Yamaoka, an internationally recognised physician, microbiologist and researcher specialising in H. pylori and gastrointestinal cancer-associated pathogens, will address “Collaborative Research in Africa: Current Progress and Future Perspectives.”
His presentation is expected to draw attention to the importance of stronger research partnerships, scientific capacity development and greater African participation in global investigations into H. pylori and related diseases.
Goodwill messages from Professor Peter Malfertheiner, a Richen Symposium, oral scientific presentations and panel discussions will also feature at the two-day conference, holding at the Grand Palace Hotel, Lusaka, amidst awards and prizes for outstanding oral presentations, the formal handover of AHMSG’s presidency and a meeting of the group’s board members.
In a statement announcing the conference, AHMSG President, Professor Mashiko Setshedi, said the gathering would provide an important opportunity to advance scientific exchange and strengthen collaboration among African and international researchers.
AHMSG has positioned itself as a continental platform for advancing research, strengthening professional collaboration and developing Africa-specific approaches to the prevention, diagnosis and management of H. pylori infection.
The Group was established to address the peculiar challenges of H. pylori infections and gastric health in Africa, with a focus on developing research-driven approaches and clinical guidelines suited to the continent.
The initiative took shape in 2021, during the COVID-19 pandemic, when a network of African medical scholars began meeting virtually to address concerns that existing international clinical guidelines for managing H. pylori infections did not adequately reflect Africa’s socioeconomic and healthcare realities.
The challenges include inadequate local research funding, poor access to healthcare services and underdeveloped diagnostic infrastructure, which often limit the effective diagnosis and treatment of the infection. Following the consultations, AHMSG was formally established and inaugurated in June 2022, in Lagos, by the then Director-General of the Nigerian Institute of Medical Research (NIMR), Professor Babatunde Lawal Salako.
The initiative was spearheaded by Professor Stella I. Smith, then Director of Research at NIMR and a renowned microbiologist, who became the group’s founding president.
Conceived as a continental scientific collaboration, AHMSG brought together leading medical researchers, scholars and board members from several African countries, including Nigeria, South Africa, Cameroon, Egypt, Kenya, Morocco, Senegal and Tanzania.
Its formation was aimed at strengthening research collaboration, knowledge sharing and scientific responses to H. pylori infections and related gastrointestinal health challenges across the continent. The group also seeks to promote the development of Africa-specific guidelines for the diagnosis, prevention and treatment of the infection, with the ultimate goal of reducing associated conditions such as stomach ulcers and gastric cancer.

No comments yet. Start the conversation.